11 Aug 2010 07:00

Â
| For immediate release | 11 August 2010 |
Â
Â
Â
Futura Medical plc
("Futura" or "the Company")
Â
 Notification of Interim Results
Â
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that it will issue its interim results for the six months ended 30 June 2010 on Wednesday 8 September 2010.
Â
A meeting for analysts will be held at 9.00am on the morning of the results at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.
Â
Â
For any further information please contact:
Â
| Futura Medical plc | Â |
| James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
| Â | Â |
| mail to: james.barder@futuramedical.com | www.futuramedical.com |
| Â | Â |
| Nomura Code Securities Limited | Â |
| Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
| Â | Â |
| For media enquiries please contact: | Â |
| Â | Â |
| Buchanan Communications | Â |
| Mark Court / George Prassas | Tel: +44 (0) 20 7466 5000 |
Â
Â
Notes to Editors
Â
Futura Medical plc
Â
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Â
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Â
www.futuramedical.com
Â
Â
Â
Futura Medical (FUM)